Nippon India Pharma Fund vs SBI Healthcare Opportunities Fund compare
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Fund | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹4082 Cr | ₹8346 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 31 Dec 2004 | 05 Jun 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 32% | 21% |
| Expense Ratio | 1.94 | 1.82 |
| Manager | Pradeep Kesavan | Sailesh Raj Bhan |
| ISIN Code | INF200K01446 | INF204K01968 |
| Exits Load | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Month | -1.38% | -0.85% |
| 6 Month | 3.68% | 2.41% |
| 1 Year | 0.58% | -0.37% |
| 3 Year | 23.5% | 20.75% |
| 5 Year | 17.99% | 16.25% |
SIP Return Analysis
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 6 Month | 1.08% | 0.99% |
| 1 Year | 7.72% | 8.09% |
| 3 Year | 20.98% | 18.15% |
| 5 Year | 19.83% | 17.13% |
Rolling Lumpsum Returns
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Year | 15.37% | 16.7% |
| 3 Year | 18% | 20.91% |
| 5 Year | 13.25% | 20.41% |
Risk Management
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Standard Deviation | 14.02% | 14.36% |
| Sharp | 1.23% | 0.95% |
| Beta | 0.8% | 0.87% |
| Alpha | 5.73% | 1.94% |
Fund Managers
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Name | Pradeep Kesavan | Sailesh Raj Bhan |
| Total AUM | ₹434274 Cr | ₹96086 Cr |
| Funds Managed | 43 | 5 |
| SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
| Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 8 | 0.33 |
| Small Cap | 33.32 | 30.05 |
| Large Cap | 39.15 | 49.27 |
| Mid Cap | 19.53 | 20.35 |
Sector Allocation
| Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 8 | 0.33 |
| Pharmaceuticals & Biotechnology | 64.15 | 75.07 |
| Healthcare Services | 21.4 | 21.28 |
| Chemicals & Petrochemicals | 2.58 | - |
| Healthcare Equipment & Supplies | 2.94 | - |
| Retailing | 0.93 | 3.32 |
Top Comparisons
ITI Balanced Advantage Fund Regular - Growth
3Y Returns10.94%
Mahindra Manulife Balanced Advantage Fund - Regular Plan - Growth
3Y Returns11.6%
Mahindra Manulife Dynamic Bond Fund - Regular Plan - Growth
3Y Returns6.68%
BANDHAN Dynamic Bond Fund - Regular Plan B - Growth
3Y Returns6.58%
HDFC Multi Cap Fund - Growth Option
3Y Returns19.04%
Quant Multi Cap Fund-Growth
3Y Returns9.18%
INVESCO INDIA FOCUSED FUND - Growth
3Y Returns20.66%
HSBC Focused Fund - Regular Growth
3Y Returns15.41%